Folic Acid, B12, and Neurodevelopmental Risk
叶酸、维生素 B12 和神经发育风险
基本信息
- 批准号:10346956
- 负责人:
- 金额:$ 41.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-10 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdolescentAnimal ModelAnimalsAnxiety DisordersApoptosisApoptoticBehavioralBiochemicalBiological AssayBloodBlood specimenBrainCarbonCerealsCerebral cortexCerebrumChildCognition DisordersConceptionsConsumptionDNA MethylationDefectDevelopmentDietEmbryoEnzymesExhibitsExposure toFolic AcidFoodGenerationsGeneticGrainGuidelinesHistologicHomocysteineHumanIn Situ Nick-End LabelingIncidenceIntakeIntellectual functioning disabilityInterneuronsInvestigationLabelLearningLeucovorinLifeLinkLiverMalabsorption SyndromesMeasuresMemoryMetabolismMethionineMethylationMethylmalonic AcidMicronutrientsMorphologyMothersMusNatural regenerationNeural Tube DefectsNeurodevelopmental DisorderNeuronal Migration DisorderNeuronsNewborn InfantOutcomePathologicPathway interactionsPatternPlacentaPlasmaPopulationPre-Clinical ModelPregnancyPregnant WomenPrevention strategyPublic HealthPublishingReactionReportingResearchRiskRisk FactorsSLC19A1 geneSeriesSerum Folate LevelSiteSocial InteractionSourceStructural defectSupplementationTestingTetrahydrofolatesTissuesUmbilical Cord BloodUnited States Food and Drug AdministrationVariantVegan DietVertebral columnVitamin B 12Vitamin B 12 DeficiencyWorkanxiety-related behaviorautism spectrum disorderbehavior testbisulfite sequencingbrain sizechildhood epilepsydensitydeprivationdietarydietary supplementsembryo tissueepidemiology studyfetalfolic acid supplementationfortificationmetabolomicsmethylation patternmultidisciplinaryneocorticalnerve stem cellneurodevelopmentneurogenesisnovelobject recognitionoffspringpregnantprenatalpreventprogenitorprogramspupsocial deficitstrendwhole genomeyoung adult
项目摘要
The research objective of this multidisciplinary proposal is to examine the neurodevelopmental, behavioral, and biochemical consequences of excessive and deficient folic acid supplementation in a preclinical model. In this context vitamin B12 deficiency, a micronutrient required for the folate cycle, will also be tested. Central to our investigation are structural defects of the cerebral cortex, the predominant site of maldevelopment in a range of neurodevelopmental disorders, including neuronal migration disorders, childhood epilepsy, intellectual disability, and autism spectrum disorders (ASD). In these conditions, changes in prenatal neurogenesis can be the principal cause of structural abnormalities, such as pathological brain size variation, cortical lamination defects, or defective cytoarchitectural integrity. Consequently, further investigating the genetic and environmental causes and consequences of dysregulated early neurogenesis is of key importance towards a better understanding of neurodevelopmental disorders and the conception of preventive strategies. In 1998, the Food and Drug Administration mandated the fortification of grain products with folic acid to reduce the incidence of neural tube defects, which in combination with rising supplementation has led to a substantial increase in folic acid intake in the US. Intriguingly, our preliminary work has confirmed that excess maternal folic acid intake can alter cortical developmental neurogenesis. The question that arises from these observations is can too much of a good thing be a bad thing? Could excess folic acid intake during pregnancy result in altered cortical neurogenesis causing cerebral structural defects with life-long consequences. This concept has obtained further relevance by recent reports from epidemiological studies that found a higher incidence of ASD cases born to mothers with highest folate levels in their blood. To comprehensively explore this question, we will administer folic acid under three different conditions, a reduced folate in excess, and both in combination with B12 deficiency to pregnant dams to create test groups of offspring that we will analyze with respect to neurodevelopmental outcomes and behavioral abnormalities associated with social, cognitive, and anxiety disorders. These studies will be accompanied by detailed biochemical investigations on brain folate pathway dysregulations, including folate transport, processing, and consequences for DNA methylation.
这项多学科提案的研究目标是在临床前模型中检查叶酸补充过量和不足对神经发育、行为和生化的影响。在这种情况下,还将测试叶酸循环所需的微量营养素维生素 B12 缺乏症。我们研究的核心是大脑皮层的结构缺陷,这是一系列神经发育障碍中发育不良的主要部位,包括神经元迁移障碍、儿童癫痫、智力障碍和自闭症谱系障碍 (ASD)。在这些情况下,产前神经发生的变化可能是结构异常的主要原因,例如病理性大脑大小变化、皮质层压缺陷或细胞结构完整性缺陷。因此,进一步研究早期神经发生失调的遗传和环境原因和后果对于更好地理解神经发育障碍和预防策略的概念至关重要。 1998年,美国食品和药物管理局强制要求在谷物产品中添加叶酸,以减少神经管缺陷的发生率,这与补充量的增加相结合,导致美国叶酸摄入量大幅增加。有趣的是,我们的初步工作已经证实,母亲摄入过多的叶酸可以改变皮质发育神经发生。这些观察产生的问题是,好事太多会变成坏事吗?怀孕期间摄入过量的叶酸是否会导致皮质神经发生改变,从而导致大脑结构缺陷,并产生终生后果。最近的流行病学研究报告发现,血液中叶酸水平最高的母亲所生自闭症谱系障碍病例的发生率更高,这一概念得到了进一步的重视。为了全面探讨这个问题,我们将在三种不同的条件下给予叶酸,叶酸过量,并结合维生素 B12 缺乏,对怀孕母鼠创建后代测试组,我们将对其神经发育结果和行为异常进行分析与社交、认知和焦虑障碍有关。这些研究将伴随着对大脑叶酸途径失调的详细生化研究,包括叶酸运输、加工和 DNA 甲基化的后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RALPH GREEN其他文献
RALPH GREEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RALPH GREEN', 18)}}的其他基金
Folic Acid, B12, and Neurodevelopmental Risk
叶酸、维生素 B12 和神经发育风险
- 批准号:
10642655 - 财政年份:2022
- 资助金额:
$ 41.4万 - 项目类别:
Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease
镰状细胞病中的维生素 B6、血管功能障碍和粘附分子
- 批准号:
7799189 - 财政年份:2007
- 资助金额:
$ 41.4万 - 项目类别:
Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease
镰状细胞病中的维生素 B6、血管功能障碍和粘附分子
- 批准号:
7394465 - 财政年份:2007
- 资助金额:
$ 41.4万 - 项目类别:
Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease
镰状细胞病中的维生素 B6、血管功能障碍和粘附分子
- 批准号:
7586149 - 财政年份:2007
- 资助金额:
$ 41.4万 - 项目类别:
Vitamin B6, Vascular Dysfunction and Adhesion Molecules in Sickle Cell Disease
镰状细胞病中的维生素 B6、血管功能障碍和粘附分子
- 批准号:
7263763 - 财政年份:2007
- 资助金额:
$ 41.4万 - 项目类别:
DESFERRIOXAMINE THERAPY IN PATIENTS WITH IRON OVERLOAD
铁过量患者的去铁胺治疗
- 批准号:
4703656 - 财政年份:
- 资助金额:
$ 41.4万 - 项目类别:
DESFERRIOXAMINE THERAPY IN PATIENTS WITH IRON OVERLOAD
铁过量患者的去铁胺治疗
- 批准号:
3976111 - 财政年份:
- 资助金额:
$ 41.4万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 41.4万 - 项目类别:
IND Enabling Non-Clinical Development of E1v1.11, a Morpholino Anti-Sense Oligonucleotide for the treatment of Spinal Muscular Atrophy.
IND 促进 E1v1.11 的非临床开发,E1v1.11 是一种用于治疗脊髓性肌萎缩症的吗啉代反义寡核苷酸。
- 批准号:
10569744 - 财政年份:2023
- 资助金额:
$ 41.4万 - 项目类别:
Defining age-associated alterations in oral squamous cell carcinoma
定义口腔鳞状细胞癌与年龄相关的改变
- 批准号:
10607387 - 财政年份:2023
- 资助金额:
$ 41.4万 - 项目类别:
Title: Development and Validation of Therapy for GM1 Gangliosidosis
标题:GM1 神经节苷脂沉积症疗法的开发和验证
- 批准号:
10678309 - 财政年份:2023
- 资助金额:
$ 41.4万 - 项目类别:
The interaction of perinatal organophosphate flame retardant exposure and adult chronic stress on cognitive processing
围产期有机磷阻燃剂暴露与成人慢性应激对认知加工的相互作用
- 批准号:
10449738 - 财政年份:2023
- 资助金额:
$ 41.4万 - 项目类别: